Group One Trading
NRXP icon

Group One Trading’s NRX Pharmaceuticals NRXP Stock Holding History

Group One Trading’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$852 Buy
400
+300
+300% +$606 ﹤0.01% 7244
2025
Q4 		$271 Sell
100
-300
-75% -$805 ﹤0.01% 7861
2025
Q3 		$1.32K Buy
400
+100
+33% +$286 ﹤0.01% 8007
2025
Q2 		$978 Sell
300
-2,200
-88% -$5.51K ﹤0.01% 7569
2025
Q1 		$5.13K Buy
+2,500
New +$7.04K ﹤0.01% 6632
2024
Q2 		– Sell
-10
Closed -$47 – 7232
2024
Q1 		$47 Buy
+10
New +$46 ﹤0.01% 6864
2023
Q3 		– Sell
-820
Closed -$3.96K – 8075
2023
Q2 		$3.96K Buy
820
+10
+1% +$60 ﹤0.01% 6819
2023
Q1 		$5.34K Sell
810
-40
-5% -$405 ﹤0.01% 6250
2022
Q4 		$9.44K Sell
850
-10
-1% -$101 ﹤0.01% 6052
2022
Q3 		$6K Sell
860
-1,700
-66% -$11.5K ﹤0.01% 6757
2022
Q2 		$15K Sell
2,560
-3,540
-58% -$46.5K ﹤0.01% 6515
2022
Q1 		$149K Buy
6,100
+770
+14% +$25K ﹤0.01% 5103
2021
Q4 		$255K Buy
5,330
+4,090
+330% +$295K ﹤0.01% 4835
2021
Q3 		$115K Buy
+1,240
New +$161K ﹤0.01% 5770

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Group One Trading's NRXP Position: Q1 2026 in Review

Group One Trading opened a new position in NRX Pharmaceuticals (NRXP) in Q1 2026: 737 shares worth $1.57K. The stake represents ﹤0.01% of the portfolio and ranks #7116 among its holdings. This is a return to the name: Group One Trading previously reported a position in NRXP as recently as Q2 2025.

Group One Trading first reported a position in NRXP in Q3 2021 and has held it in 14 quarters since. The position peaked at $104K in Q2 2022. 33 funds tracked by Wall St. Rank hold NRXP as of Q1 2026.

  • Group One Trading held 737 shares of NRX Pharmaceuticals worth $1.57K as of Q1 2026.
  • NRX Pharmaceuticals was a new Group One Trading position in Q1 2026.
  • NRX Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7116 holding.
  • Group One Trading first reported a position in NRX Pharmaceuticals in Q3 2021 and has held it in 14 quarters since.
  • Group One Trading's NRX Pharmaceuticals position peaked at $104K in Q2 2022.
  • 33 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.